170 WPPh (Sulindac 150 mg)
Pill imprint 170 WPPh has been identified as Sulindac 150 mg.
Sulindac is used in the treatment of rheumatoid arthritis; pain; osteoarthritis; juvenile rheumatoid arthritis; familial adenomatous polyposis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Sulindac 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 170 WPPh (Sulindac 150 mg)
Sulindac is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...